Byetta, every mention
7 scenes · ← back to Byetta
tap a year for its mentions
every year anyone David Rosenthal 7
Verbatim, from the transcripts: the passages where Byetta comes up
Novo Nordisk (Ozempic) · Acquired
- ▶ 1:51:12 David Rosenthal When the world's first GLP-I analog drug finally comes to market for the treatment of type-II diabetes, of course, I'm talking about the world-famous, well-known, Bayetta from Eli Lilly.
- ▶ 1:54:11 David Rosenthal Eli Lilly develops it into Bayetta, and Bayetta hits the market in 2005.
- ▶ 1:54:37 David Rosenthal And more importantly, the half-life is not as good as liraglutide, so Bietta requires two injections per day, which, you know, if you're a type two diabetic
- ▶ 1:58:22 David Rosenthal So, as they're in trials, and Novo knew this, but it's starting to get confirmed, that one, liraglutide is going to be more effective than bietta.
- ▶ 2:04:09 David Rosenthal As recently as 2005, 2005, like same year Baeta came out, Novo Nordisk's own official position on the obesity category, as articulated by the then CEO Lars Sorensen, was quote, Obesity is primarily a social and cultural problem.
- ▶ 2:08:14 David Rosenthal So five years after Bayetta, Victoza is finally officially hitting the market in the US.
- ▶ 2:08:36 David Rosenthal It doesn't just overtake Bayetta as the leading GLP one drug on the market for diabetes.